| Preferred Name |
biapenem |
| Synonyms |
LJC 10627 |
| ID |
http://purl.bioontology.org/ontology/MESH/C065257 |
| altLabel |
LJC 10627 L 627 L-627 CLI 86815 5H-Pyrazolo(1,2-a)(1,2,4)triazol-4-ium, 6-((2-carboxy-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-en-3-yl)thio)-6,7-dihydro-, hydroxide, inner salt, (4R-(4alpha,5beta,6beta(R*)))- CLI 86,815 LJC-10627 LJC10,627 3-((6,7-dihydro-5H-pyrazolo(1,2-a)(1,2,4)triazol-4-ium-6-yl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3,2,0)hept-2-ene-2-carboxylate CLI-86815 |
| cui |
C0209474 C0171273 C0209475 C0209473 |
| HM |
D013845 |
| Inverse of RB |
YR5U3L9ZH1 0 |
| isa | |
| Mapped to | |
| MDA |
19900911 |
| MeSH Frequency |
162 |
| MMR |
20161103 |
| notation |
C065257 |
| PA |
D000890 |
| PI |
*CARBAPENEMS (90-93) |
| prefLabel |
biapenem |
| RR |
120410-24-4 |
| SC |
1 |
| Scope Statement |
structure given in first source |
| SRC |
Antimicrob Agents Chemother 1990;34(6):994 |
| TERMUI |
T209490 T209489 T209487 T209485 T209484 T209486 T209483 T209482 T209491 T209488 |
| TH |
USAN (1993) FDA SRS (2017) NLM (1990) INN (19XX) |
| tui |
T109 T195 |